© Funtap / Shutterstock.com
Quantinuum, the Honeywell-backed trapped-ion quantum computing firm, started buying and selling on the NASDAQ right this moment after pricing its IPO at $60 per share and elevating $1.68 billion. On CNBC’s Squawk Box this morning, CEO Rajeeb Hazra delivered the road that may outline the debut: “It is not 10 to 15 years out. It’s very much now. And we will only see acceleration going forward.”
That is a daring framing on a day when traders are additionally digesting the corporate’s early-stage financials. It can be a direct problem to the long-running skeptic view that quantum continues to be a science undertaking.
The Debut
Quantinuum was spun out of Honeywell, which stays a majority shareholder post-IPO. The firm builds trapped-ion quantum computer systems, together with {hardware} known as Helios. Trapped-ion programs use charged atoms held in electromagnetic fields as qubits, an strategy valued for prime gate constancy and accuracy. It is similar broad structure utilized by IonQ (NYSE:IONQ | IONQ Price Prediction), making IonQ the closest public comparable for traders attempting to triangulate Quantinuum’s positioning.
The “Very Much Now” Thesis
Hazra’s pitch leans on prospects fairly than principle. “We have customers today that are using our commercially available hardware and software, our full stack, to get started with their quantum journey on transforming, whether it’s their product set is pharma, their product set is financial instruments, their product set is new chemicals,” he mentioned. He additionally tied quantum straight to the AI buildout: (*10*)
He acknowledged the stage of the market, calling it “early days of a massive industry,” the place the KPIs are {hardware} efficiency and accuracy.
The Profitability Question
Here is the place traders will scrutinize the story. Quantinuum reported 2025 income of $31 million and 2025 bookings of $79 million, however Q1 2026 income was solely $1.3 million. The hole between booked commitments and acknowledged income is the central rigidity. Lumpy income is typical for pre-mass-commercialization deep tech, and the general public comps present the identical sample in several kinds. IonQ posted Q1 FY26 income of $64.67M, up 755% YoY, whereas D-Wave Quantum (NYSE:QBTS) reported Q1 FY26 income of $2.86M, down 81% YoY towards a tricky prior-year system-sale comp.
Government Validation and the Quantum IPO Wave
Hazra confirmed Quantinuum has signed a Department of Commerce LOI: “This R&D grant is intended to allow us to be able to scale those technologies, including supply chain onshore in the US.” That ties right into a broader theme. The Commerce Department’s $2 billion quantum initiative, introduced May 21, 2026, included $100 million deliberate for D-Wave, $100 million for Quantinuum, and up to $100 million for Rigetti. Washington is treating quantum as strategic infrastructure.
For traders who need publicity right this moment, the general public comps are the established route. IonQ trades at roughly a $26.65 billion market cap with a P/E of 183 and an analyst consensus goal of $67.64 ( 11 Buy, 2 Hold, 0 Sell). Polymarket assigns a 53.5% likelihood that the US federal authorities takes a stake in IonQ by year-end.
D-Wave runs each annealing and gate-model programs and is up 31.69% over the previous month. Rigetti Computing (NASDAQ:RGTI) pursues superconducting chiplet structure and has gained 100.12% over the previous 12 months. These are completely different architectures with completely different threat profiles, not equivalents to Quantinuum. For deeper background on how the architectures evaluate, see our protection of the D-Wave vs. IonQ matchup.
The Takeaway
Quantinuum’s itemizing is an actual milestone. A well-funded, Honeywell-backed, government-validated trapped-ion firm is now public, and its CEO insists the business period has began. The quantity to watch is the conversion of bookings into acknowledged income. CEO Hazra is asking traders to consider in acceleration. The financials say it’s nonetheless early days. Quantum is shifting from lab to market, and traders ought to measurement positions with that distinction in thoughts.